CY1105697T1 - Μεθοδοι και αντιδραστηρια ανιχνευσης καρκινου - Google Patents
Μεθοδοι και αντιδραστηρια ανιχνευσης καρκινουInfo
- Publication number
- CY1105697T1 CY1105697T1 CY20061100772T CY061100772T CY1105697T1 CY 1105697 T1 CY1105697 T1 CY 1105697T1 CY 20061100772 T CY20061100772 T CY 20061100772T CY 061100772 T CY061100772 T CY 061100772T CY 1105697 T1 CY1105697 T1 CY 1105697T1
- Authority
- CY
- Cyprus
- Prior art keywords
- reagents
- detection methods
- cancer detection
- autoantibodies
- methods
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 239000003153 chemical reaction reagent Substances 0.000 title 1
- 238000001514 detection method Methods 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000000439 tumor marker Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Ευαίσθητες και εξειδικευμένες μέθοδοι παρέχονται για χρήση στην ανίχνευση της παρουσίας πρωτεϊνών δεικτών καρκίνου στα σωματικά υγρά ενός θηλαστικού. Επίσης παρέχονται αυτοαντισώματα για χρήση σε αυτές τις μεθόδους, και αθανατοποιημένα κύτταρα τα οποία είναι μια πηγή των αυτοαντισωμάτων.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9827228.9A GB9827228D0 (en) | 1998-12-10 | 1998-12-10 | Cancer detection method and reagents |
PCT/GB1999/004182 WO2000034787A1 (en) | 1998-12-10 | 1999-12-10 | Cancer detection method and reagents |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1105697T1 true CY1105697T1 (el) | 2010-12-22 |
Family
ID=10844007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20061100772T CY1105697T1 (el) | 1998-12-10 | 2006-06-08 | Μεθοδοι και αντιδραστηρια ανιχνευσης καρκινου |
Country Status (13)
Country | Link |
---|---|
US (2) | US7205117B1 (el) |
EP (1) | EP1137943B1 (el) |
JP (1) | JP4665069B2 (el) |
AT (1) | ATE322014T1 (el) |
AU (1) | AU1671300A (el) |
CA (1) | CA2354702C (el) |
CY (1) | CY1105697T1 (el) |
DE (1) | DE69930666T2 (el) |
DK (1) | DK1137943T3 (el) |
ES (1) | ES2257087T3 (el) |
GB (1) | GB9827228D0 (el) |
PT (1) | PT1137943E (el) |
WO (1) | WO2000034787A1 (el) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9810040D0 (en) | 1998-05-11 | 1998-07-08 | Univ Nottingham | Blood borne tumour markers |
US20030232399A1 (en) * | 2000-06-14 | 2003-12-18 | Robertson John Forsyth Russell | Cancer detection methods and reagents |
GB2395270B (en) | 2002-11-14 | 2006-08-16 | Univ Nottingham | Tumour marker proteins and uses thereof |
US20040137538A1 (en) * | 2003-01-10 | 2004-07-15 | Bradford Sherry A. | Cancer comprehensive assay kit for identifying cancer protein patterns |
US7858323B2 (en) | 2004-06-09 | 2010-12-28 | The Regents Of The University Of Michigan | Phage microarray profiling of the humoral response to disease |
ATE527285T1 (de) * | 2005-01-28 | 2011-10-15 | Univ Ramot | Anti-muc1-alpha-beta-antikörper |
GB2426581A (en) | 2005-05-27 | 2006-11-29 | Univ Nottingham | Immunoassay methods |
BRPI0610267B8 (pt) | 2005-05-27 | 2021-07-27 | Oncimmune Ltd | métodos de detecção de um estado doentio ou de uma suscetibilidade à doença em um indivíduo mamífero, e, uso do método |
US20090197285A1 (en) * | 2005-11-10 | 2009-08-06 | University Of Kentucky | Lung Cancer Diagnostic Assay |
EP2041569A4 (en) * | 2006-07-08 | 2009-11-18 | Univ Kentucky Res Found | DIAGNOSTIC TEST OF LUNG CANCER |
CN101632020B (zh) | 2006-09-13 | 2013-11-27 | 昂西免疫有限公司 | 改进的免疫测定方法 |
US9111950B2 (en) * | 2006-09-28 | 2015-08-18 | Philips Lumileds Lighting Company, Llc | Process for preparing a semiconductor structure for mounting |
MX2009005466A (es) | 2006-11-22 | 2009-08-17 | Adnexus A Bristol Myers Sqibb | Terapeuticos dirigidos a base de proteinas manipuladas para receptores de tirosina cinasas, incluyendo receptor de factor de crecimiento tipo insulina-i. |
GB0725239D0 (en) * | 2007-12-24 | 2008-02-06 | Oncimmune Ltd | Calibrator for autoantibody assay |
US8642347B2 (en) * | 2008-01-31 | 2014-02-04 | The Brigham And Women's Hospital, Inc. | Urinary CA125 peptides as biomarkers of ovarian cancer |
WO2009102421A2 (en) | 2008-02-14 | 2009-08-20 | Bristol-Myers Squibb Company | Targeted therapeutics based on engineered proteins that bind egfr |
US20120003225A1 (en) * | 2008-05-09 | 2012-01-05 | Duke University | Autoantibodies in the detection and treatment of cancer |
AR071874A1 (es) | 2008-05-22 | 2010-07-21 | Bristol Myers Squibb Co | Proteinas de dominio de armazon basadas en fibronectina multivalentes |
WO2010005718A1 (en) * | 2008-06-16 | 2010-01-14 | University Of Louisville Research Foundation, Inc | Systems and methods for diagnosis and prognosis of cancer |
TWI496582B (zh) | 2008-11-24 | 2015-08-21 | 必治妥美雅史谷比公司 | 雙重專一性之egfr/igfir結合分子 |
EP2548025A4 (en) * | 2010-03-17 | 2013-09-25 | Univ Michigan | USE OF PHOTOEPITOPES FOR PROFILING AN IMMUNE REACTION |
WO2011120015A2 (en) * | 2010-03-26 | 2011-09-29 | Armune Biosciences, Inc. | Method and system of particle-coupled phage epitope |
TW201138808A (en) | 2010-05-03 | 2011-11-16 | Bristol Myers Squibb Co | Serum albumin binding molecules |
EP2576615B1 (en) | 2010-05-26 | 2016-03-30 | Bristol-Myers Squibb Company | Fibronectin based scaffold proteins having improved stability |
CN102680456B (zh) * | 2011-03-16 | 2015-07-08 | 北京联众泰克科技有限公司 | 一种电化学发光免疫测定方法 |
PL2697257T3 (pl) | 2011-04-13 | 2017-04-28 | Bristol-Myers Squibb Company | Białka fuzyjne fc o nowatorskim układzie lub zawierające nowatorskie łączniki |
WO2012158678A1 (en) | 2011-05-17 | 2012-11-22 | Bristol-Myers Squibb Company | Methods for maintaining pegylation of polypeptides |
US20130040839A1 (en) * | 2011-06-27 | 2013-02-14 | Ambergen, Inc. | Method for Diagnosing or Determining the Prognosis of Colorectal Cancer (CRC) Using Novel Autoantigens: Gene Expression Guided Autoantigen Discovery |
WO2013038412A2 (en) | 2011-09-15 | 2013-03-21 | Vaxil Bio Therapeutics Ltd. | Antibodies directed against signal peptides, methods and uses thereof |
KR20220162886A (ko) | 2014-03-20 | 2022-12-08 | 브리스톨-마이어스 스큅 컴퍼니 | 혈청 알부민-결합 피브로넥틴 유형 iii 도메인 |
GB201501930D0 (en) | 2015-02-05 | 2015-03-25 | Univ London Queen Mary | Biomarkers for pancreatic cancer |
EP3281016A1 (en) | 2015-04-10 | 2018-02-14 | Applied Proteomics Inc. | Protein biomarker panels for detecting colorectal cancer and advanced adenoma |
WO2017053617A1 (en) | 2015-09-23 | 2017-03-30 | Bristol-Myers Squibb Company | Fast-off rate serum albumin binding fibronectin type iii domains |
CN109116024B (zh) * | 2018-06-14 | 2021-04-23 | 郑州大学第一附属医院 | 一种肺癌标志物抗-actr3自身抗体及其应用 |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4241044A (en) * | 1978-12-28 | 1980-12-23 | Abbott Laboratories | Method of diagnosing cancer by detecting elevated anti-T antibody activity |
US4562160A (en) * | 1983-04-01 | 1985-12-31 | Sloan-Kettering Institute | Melanoma tumor antigen and autologous antibody |
US5106738A (en) * | 1984-01-31 | 1992-04-21 | Akzo Nv | Tumor specific monoclonal antibodies |
NZ211453A (en) | 1984-03-22 | 1989-01-06 | Biotechnology Research Enterpr | Aryl azides, their preparation and use in the detection, localisation and isolation of polynucleotides |
ATE77700T1 (de) | 1986-03-10 | 1992-07-15 | Imre Corp | Immunkomplextestverfahren. |
US4937185A (en) | 1987-07-31 | 1990-06-26 | The Ohio State University Research Foundation | Detection of circulating antibodies to a cancer marker protein |
US7282345B1 (en) * | 1989-08-04 | 2007-10-16 | Schering Ag | C-erbB-2 external domain: GP75 |
US5110911A (en) * | 1989-11-02 | 1992-05-05 | Biomira, Inc. | Human tumor-associated thomsen-friedenreich antigen |
US5157020A (en) * | 1990-05-24 | 1992-10-20 | Research Corporation Tech., Inc. | Synthetic senescent cell antigen |
DK9091D0 (da) * | 1991-01-18 | 1991-01-18 | Novo Nordisk As | Fremgangsmaade til fremstilling af antistoffer |
DE4120412C1 (el) * | 1991-06-20 | 1993-01-07 | Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin, De | |
US6322989B1 (en) | 1991-11-25 | 2001-11-27 | Yoreh Biotechnologies, Ltd. | Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit |
US6280962B1 (en) * | 1991-11-25 | 2001-08-28 | Yoreh Biotechnologies Ltd. | Whole blood/mitogen assay for the early detection of a subject with cancer and kit |
PT1024191E (pt) * | 1991-12-02 | 2008-12-22 | Medical Res Council | Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos |
EP0636248A4 (en) | 1992-04-14 | 1996-11-13 | Univ Duke | METHOD FOR DETECTING P53 AND HSP70 COMPLEX CONTAINING TUMORS. |
US5801005A (en) | 1993-03-17 | 1998-09-01 | University Of Washington | Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated |
US5763164A (en) | 1993-04-16 | 1998-06-09 | Northwestern University | Immunogenic cancer proteins and peptides and methods of use |
US5747268A (en) * | 1993-04-22 | 1998-05-05 | Dade International Inc. | Tumor marker control |
IT1270939B (it) * | 1993-05-11 | 1997-05-26 | Angeletti P Ist Richerche Bio | Procedimento per la preparazione di immunogeni e reagenti diagnostici,e immunogeni e reagenti diagnostici cosi' ottenibili. |
US5744144A (en) * | 1993-07-30 | 1998-04-28 | University Of Pittsburgh University Patent Committee Policy And Procedures | Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
US5721105A (en) * | 1994-02-20 | 1998-02-24 | B.R.A.H.M.S. Diagnostica Gmbh | Method for the immunological determination of proteins and kit for carrying out the method |
EP0764030B1 (en) * | 1994-06-24 | 2000-09-20 | Vladimir P. Torchilin | Composition containing autoantibodies for tumor therapy and prophylaxis |
IL110464A0 (en) | 1994-07-26 | 1994-10-21 | Univ Ramot | Novel proteins for the diagnosis, imaging, and therapy of human cancer |
US5561049A (en) * | 1994-09-21 | 1996-10-01 | Behringwerke Ag | Method for detecting antibodies |
US5876728A (en) | 1995-02-15 | 1999-03-02 | Howard David Kass | Natural composition extracted from plants used in the treatment of cancer |
GB9521544D0 (en) | 1995-10-20 | 1995-12-20 | Univ Dundee | Activation of P53 protein and therapeutic applications thereof |
JPH09189702A (ja) | 1996-01-09 | 1997-07-22 | Hitachi Chem Co Ltd | 抗ムチン抗体の測定法、癌の測定法及び癌診断薬 |
ATE283069T1 (de) * | 1996-08-16 | 2004-12-15 | Univ Johns Hopkins Med | Melanomzellinien, welche immundominante melanomantigene teilen und verfahren zu deren anwendung |
DE19805815C1 (de) * | 1998-02-13 | 1999-11-11 | Ansgar W Lohse | Diagnostikum zum Erkennen der autoimmunen Hepatitis |
GB9810040D0 (en) * | 1998-05-11 | 1998-07-08 | Univ Nottingham | Blood borne tumour markers |
EP1125134B1 (en) | 1998-11-05 | 2009-11-04 | The Regents Of The University Of Michigan | S100 proteins and autoantibodies as serum markers for cancer |
US6387639B1 (en) * | 1998-11-10 | 2002-05-14 | Sloan-Kettering Institute For Cancer Research | Ma family polypeptides and anti-Ma antibodies |
US7807810B2 (en) * | 1999-04-08 | 2010-10-05 | The Ohio State University Research Foundation | Nucleic acids encoding the major outer membrane protein of the causative agent of human granulocytic ehrlichiosis and peptides encoded thereby |
US6645465B2 (en) * | 1999-08-06 | 2003-11-11 | Michigan, University Of The Regents | Annexin proteins and autoantibodies as serum markers for cancer |
US20020064801A1 (en) * | 1999-12-01 | 2002-05-30 | Ryan Jeffrey R. | Novel and practical serological assay for the clinical diagnosis of leishmaniasis |
US6667160B2 (en) * | 2000-03-15 | 2003-12-23 | Kenneth D. Fine | Method for diagnosing immunologic food sensitivity |
US20030232399A1 (en) * | 2000-06-14 | 2003-12-18 | Robertson John Forsyth Russell | Cancer detection methods and reagents |
US20030138860A1 (en) * | 2000-06-14 | 2003-07-24 | Robertson John Forsyth Russell | Cancer detection methods and reagents |
CA2451045A1 (en) * | 2001-06-21 | 2003-09-04 | New York University | Mycobacterial proteins as early antigens for serodiagnosis and vaccines |
US20030049692A1 (en) * | 2002-09-16 | 2003-03-13 | Norman Latov | Detection of anti-glycolipid antibodies by latex agglutination assay |
GB2395270B (en) * | 2002-11-14 | 2006-08-16 | Univ Nottingham | Tumour marker proteins and uses thereof |
JP2005352771A (ja) * | 2004-06-10 | 2005-12-22 | Hitachi Software Eng Co Ltd | 発現プロファイルによるパターン認識システム |
US20060141547A1 (en) * | 2004-11-16 | 2006-06-29 | Das Hasi R | Novel diagnostic marker, a diagnostic kit and a method for diagnosis of rheumatoid arthritis |
GB2426581A (en) * | 2005-05-27 | 2006-11-29 | Univ Nottingham | Immunoassay methods |
EP1789435B1 (en) * | 2005-09-12 | 2010-02-24 | Industry Foundation of Chonnam National University | A method for production of mature natural killer cell |
TWI304443B (en) * | 2005-12-30 | 2008-12-21 | Nat Health Research Institutes | Alpha-enolase specific antibody and method of use |
CN101632020B (zh) * | 2006-09-13 | 2013-11-27 | 昂西免疫有限公司 | 改进的免疫测定方法 |
GB0725239D0 (en) * | 2007-12-24 | 2008-02-06 | Oncimmune Ltd | Calibrator for autoantibody assay |
-
1998
- 1998-12-10 GB GBGB9827228.9A patent/GB9827228D0/en not_active Ceased
-
1999
- 1999-12-10 WO PCT/GB1999/004182 patent/WO2000034787A1/en active IP Right Grant
- 1999-12-10 DK DK99959578T patent/DK1137943T3/da active
- 1999-12-10 EP EP99959578A patent/EP1137943B1/en not_active Expired - Lifetime
- 1999-12-10 PT PT99959578T patent/PT1137943E/pt unknown
- 1999-12-10 AT AT99959578T patent/ATE322014T1/de active
- 1999-12-10 AU AU16713/00A patent/AU1671300A/en not_active Abandoned
- 1999-12-10 CA CA2354702A patent/CA2354702C/en not_active Expired - Fee Related
- 1999-12-10 JP JP2000587190A patent/JP4665069B2/ja not_active Expired - Fee Related
- 1999-12-10 ES ES99959578T patent/ES2257087T3/es not_active Expired - Lifetime
- 1999-12-10 DE DE69930666T patent/DE69930666T2/de not_active Expired - Lifetime
-
2001
- 2001-06-08 US US09/857,739 patent/US7205117B1/en not_active Expired - Fee Related
-
2006
- 2006-06-08 CY CY20061100772T patent/CY1105697T1/el unknown
-
2007
- 2007-03-05 US US11/681,830 patent/US20080108084A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1137943B1 (en) | 2006-03-29 |
CA2354702A1 (en) | 2000-06-15 |
DE69930666D1 (de) | 2006-05-18 |
JP4665069B2 (ja) | 2011-04-06 |
ATE322014T1 (de) | 2006-04-15 |
JP2002532686A (ja) | 2002-10-02 |
ES2257087T3 (es) | 2006-07-16 |
US20080108084A1 (en) | 2008-05-08 |
PT1137943E (pt) | 2006-08-31 |
DK1137943T3 (da) | 2006-07-31 |
WO2000034787A1 (en) | 2000-06-15 |
EP1137943A1 (en) | 2001-10-04 |
US7205117B1 (en) | 2007-04-17 |
AU1671300A (en) | 2000-06-26 |
DE69930666T2 (de) | 2007-01-11 |
GB9827228D0 (en) | 1999-02-03 |
CA2354702C (en) | 2013-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1105697T1 (el) | Μεθοδοι και αντιδραστηρια ανιχνευσης καρκινου | |
CY1116265T1 (el) | Kit ραδιοεπισημανσης και προσδιορισμος δεσμευσης | |
WO2000058514A3 (en) | Methods for improving sensitivity and specificity of screening assays | |
DE69735445D1 (de) | Abspaltbare, nicht-flüchtige moleküle zur massenmarkierung | |
PT1078264E (pt) | Marcadores de tumores | |
CY1108294T1 (el) | Πρωτεϊνες καρκινικων δεικτων και οι χρησεις τους | |
DE69929237D1 (de) | Strahlungsnachweisgerät | |
IT1170324B (it) | Dispositivo di rivelazione con rilevatore volumetrico ad infrasuoni, e relativo procedimento di rivelazione tramite infrasuoni | |
WO1995016919A3 (en) | Methods and compositions for the detection of colon cancers | |
CY1105025T1 (el) | Αναλυση λεπτινης βασιζομενη στην ανιχνευση εκφρασης ang-2 | |
BR9812783A (pt) | "sistemas de detecção para o registro de interações e as relações funcionais de proteìnas" | |
DE69928361D1 (de) | Strahlungsermittlungsvorrichtung | |
ATE356357T1 (de) | Prostatakrebs-marker | |
FI955415A0 (fi) | MTS-geeni, sen mutaatiot ja menetelmät syövän toteamiseksi MTS-geenisekvenssejä käyttäen | |
ES2141249T3 (es) | Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores. | |
NO20003515L (no) | FremgangsmÕte for identifisering av validerte mÕl- og analysekombinasjoner | |
DE69930185D1 (de) | Abtastende Fluoreszenznachweisvorrichtung | |
CY1107636T1 (el) | Πρωτεϊνες moraxella catarrhalis | |
DE60014064D1 (de) | Einetenascin-c isoform als marker für neoplasmen | |
BR0213997A (pt) | Métodos de detecção e identificação de bactérias entéricas | |
CY1108512T1 (el) | Μεθοδος και τυποποιημενη συσκευασια για ανιχνευση της αλκαλικης σφιγγομυελινασης | |
IL147486A0 (en) | Methods and reagents for determining the prognosis of cancer patients by measuring bag proteins | |
NO20032391L (no) | Ekspresjonsanalyse av KIAA-nukleinsyrer og polypeptider anvendelige i diagnose og behandling av prostatakreft | |
WO2000060119A3 (en) | Methods for detecting cancer cells | |
CY1106705T1 (el) | Δοκιμασια για μετρηση ολο-τρανσκοβαλαμινης και φολικου |